Healthcare & Medical Devices
Pathology Lab Equipment Market Size & Share, By Application (Diagnostics, Clinical Chemistry Testing, Hematology Testing, Microbiology Testing) and End User (Hospital-based Laboratories, Diagnostic and Clinical Laboratories, Reference Laboratories) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Pathology Lab Equipment Market size is expected to expand from USD 17.57 billion in 2024 to USD 36.21 billion by 2034, demonstrating a CAGR of more than 7.5% between 2025 and 2034. In 2025, the industry revenue is estimated to reach USD 18.62 billion.
Published Date: Mar-2025
Gynecological Drugs Market Size & Share, By Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control)), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Gynecological Drugs Market size is predicted to grow from USD 16.78 billion in 2024 to USD 35.23 billion by 2034, reflecting a CAGR of over 7.7% from 2025 through 2034. The industry revenue is forecasted to reach USD 17.81 billion in 2025.
Published Date: Mar-2025
Bile Duct Cancer Drug Market Size & Share, By Type (5-fluorouracil (5-FU), Gemcitabine, Cisplatin, Capecitabine, Oxaliplatin), Application (Hospitals, Clinics) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Bile Duct Cancer Drug Market size is expected to see substantial growth, increasing from USD 3.02 billion in 2024 to USD 6.96 billion by 2034, at a CAGR of over 8.7%. By 2025, the industry revenue is estimated to be USD 3.23 billion.
Published Date: Mar-2025
Overactive Bladder Treatment Market Size & Share, By Pharmacotherapy (Anticholinergic, Botox), Disease (Neurogenic Overactive Bladder and Idiopathic Overactive Bladder) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Overactive Bladder Treatment Market size is projected to rise from USD 3.87 billion in 2024 to USD 6.36 billion by 2034, representing a CAGR above 5.1% for the 2025–2034 forecast period. The industry is estimated to reach USD 4.03 billion in revenue by 2025.
Published Date: Mar-2025
Drug Discovery Services Market Size & Share, By Type (Pharmacokinetics and Drug Metabolism, Biology Services, Medicinal Chemistry), Process (Target Validation, Target Selection, Hit-To-Lead Identification, Candidate Validation, Lead Optimization), Drug Type (Biologics and Small Molecules), Therapeutic Area (Neurology, Diabetes, Oncology, Respiratory Diseases, Cardiovascular Diseases) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Drug Discovery Services Market size is forecast to grow from USD 22.81 billion to USD 91.48 billion between 2025 and 2034, marking a CAGR of more than 14.9%. The expected industry revenue in 2025 is USD 25.53 billion.
Published Date: Mar-2025
Contract Research Organization Market Size & Share, By Service Type (Clinical Research Services, Early-Phase Development Services, Laboratory Services, Consulting Services), Therapeutic Area (Oncology, Infectious Diseases, Central Nervous System (CNS) Disorders, Immunological Disorders, Cardiovascular Diseases, Respiratory Disorders, Diabetes), End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Contract Research Organization Market size is set to increase from USD 81.81 billion in 2024 to USD 165.5 billion by 2034, with a projected CAGR exceeding 7.3% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 86.59 billion.
Published Date: Mar-2025
Psoriatic Arthritis Therapeutics Market Size & Share, By Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors), Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, Arthritis Mutilans), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Psoriatic Arthritis Therapeutics Market size is anticipated to grow significantly, reaching USD 31.35 billion by 2034, up from USD 12.31 billion. This growth represents a CAGR of over 9.8%, with a revenue forecast of USD 13.28 billion for 2025.
Published Date: Mar-2025
Critical Limb Ischemia Treatment Market Size & Share, By Treatment (Devices and Medications) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Critical Limb Ischemia Treatment Market size is set to grow from USD 4.87 billion in 2024 to USD 9.85 billion by 2034, reflecting a CAGR of more than 7.3% between 2025 and 2034. In 2025, the industry is estimated to generate USD 5.15 billion in revenue.
Published Date: Mar-2025
Patient Lifting Equipment Market Size & Share, By Product (Ceiling Lifts, Star & Wheelchair Lifts, Mobile Lifts, Sit-to-Stand Lifts, Bath & Pool Lifts, Lifting Slings, Lifting Accessories), End User (Hospitals, Home Care Settings, Elderly Care facilities) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Patient Lifting Equipment Market size is predicted to reach USD 11.01 billion by 2034, up from USD 5.81 billion in 2024, reflecting a CAGR of over 6.6% during the forecast period from 2025 to 2034. The industry revenue for 2025 is projected to be USD 6.12 billion.
Published Date: Mar-2025
Vitamin D Therapy Market Size & Share, By Route of Administration (Oral and Parenteral), Purchasing Pattern (OTC Drugs and Prescription Drugs), Application (Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders), Age Group (Children, Adults, Senior Adults) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Vitamin D Therapy Market size is projected to grow from USD 3.42 billion in 2024 to USD 10.07 billion by 2034, with a CAGR surpassing 11.4% throughout the forecast period (2025-2034). The industry revenue for 2025 is anticipated to be USD 3.73 billion.
Published Date: Mar-2025
Vitamin D Testing Market Size & Share, By Test (25-Hydroxy D Vitamin, 1,25-Dihydroxy D Vitamin), Technique (Radioimmunoassay, ELISA, HPLC, LC-MS), Indication (Osteoporosis, Rickets, Thyroid Disorders, Malabsorption, Vitamin D Deficiency), End User (Hospitals, Diagnostic Laboratories, Home Care, Point-of-care) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Vitamin D Testing Market size is expected to expand from USD 7.47 billion in 2024 to USD 12.52 billion by 2034, demonstrating a CAGR of more than 5.3% between 2025 and 2034. In 2025, the industry revenue is estimated to reach USD 7.79 billion.
Published Date: Mar-2025
Retinal Biologics Market Size & Share, By Drug Class (TNF-a Inhibitor and VEGF-A Antagonist), Indication (Diabetic Retinopathy, Macular Degeneration, Uveitis, Diabetic Macular Edema), Distribution Channel (Retail Sales and Institutional Sales) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Retinal Biologics Market size is predicted to grow from USD 26.77 billion in 2024 to USD 58.87 billion by 2034, reflecting a CAGR of over 8.2% from 2025 through 2034. The industry revenue is forecasted to reach USD 28.53 billion in 2025.
Published Date: Mar-2025
Generic Oncology Drugs Market Size & Share, By Molecule (Large and Small), Administration Route (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Generic Oncology Drugs Market size is expected to see substantial growth, increasing from USD 27.71 billion in 2024 to USD 51.05 billion by 2034, at a CAGR of over 6.3%. By 2025, the industry revenue is estimated to be USD 29.11 billion.
Published Date: Mar-2025
Aspergillus Drugs Market Size & Share, By product type (Triazoles) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Aspergillus Drugs Market size is projected to rise from USD 3.3 billion in 2024 to USD 5.12 billion by 2034, representing a CAGR above 4.5% for the 2025–2034 forecast period. The industry is estimated to reach USD 3.42 billion in revenue by 2025.
Published Date: Mar-2025
Hemophilia Treatment Market Size & Share, By Type (Hemophilia A, Hemophilia B, Hemophilia C), Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Antifibrinolytic Agents, Desmopressin), Therapy (Replacement and Gene) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Hemophilia Treatment Market size is forecast to grow from USD 17.26 billion to USD 32.4 billion between 2025 and 2034, marking a CAGR of more than 6.5%. The expected industry revenue in 2025 is USD 18.16 billion.
Published Date: Mar-2025
Hematology Analyzers and Reagents Market Size & Share, By Product Type (Reagents and Instruments), End-User (Diagnostics Labs, Research Institutions, Hospitals) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Hematology Analyzers and Reagents Market size is set to increase from USD 8.58 billion in 2024 to USD 17.36 billion by 2034, with a projected CAGR exceeding 7.3% from 2025 to 2034. The industry revenue for 2025 is anticipated to hit USD 9.08 billion.
Published Date: Mar-2025
Organ Transplant Immunosuppressant Drugs Market Size & Share, By Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors), Transplant Type (Pancreas, Lung, Heart, Liver, Kidney), Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Organ Transplant Immunosuppressant Drugs Market size is anticipated to grow significantly, reaching USD 7.71 billion by 2034, up from USD 5.57 billion. This growth represents a CAGR of over 3.3%, with a revenue forecast of USD 5.72 billion for 2025.
Published Date: Mar-2025
Fertility Supplements Market Size & Share, By Ingredient (Natural and Synthetic/ Blend of Natural & Synthetic), Ingredient (Capsules, Tablets, Soft Gels, Powders, Liquids), End-Use (Men and Women), Distribution Channel (OTC and Prescribed) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Fertility Supplements Market size is set to grow from USD 35.5 billion in 2024 to USD 67.9 billion by 2034, reflecting a CAGR of more than 6.7% between 2025 and 2034. In 2025, the industry is estimated to generate USD 37.4 billion in revenue.
Published Date: Mar-2025
Automated Cannabis Testing Market Size & Share, By Product Type (Chromatography Based Analyzer and Spectroscopy Based Analyzer), Application (Pain Management, Seizures, Sclerosis), End-Use (Consumers, Regulators, Laboratories) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Automated Cannabis Testing Market size is predicted to reach USD 5.45 billion by 2034, up from USD 1.82 billion in 2024, reflecting a CAGR of over 11.6% during the forecast period from 2025 to 2034. The industry revenue for 2025 is projected to be USD 1.99 billion.
Published Date: Mar-2025
Macular Degeneration Treatment Market Size & Share, By Drug Class (Anti-VEGFs), Indication (Wet Age-related Macular Degeneration (wAMD) and Dry Age-related Macular Degeneration (dAMD)), Distribution Channel (Ambulatory Surgical Centers, Ophthalmic Clinics and Hospitals) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Macular Degeneration Treatment Market size is projected to grow from USD 10.85 billion in 2024 to USD 24.53 billion by 2034, with a CAGR surpassing 8.5% throughout the forecast period (2025-2034). The industry revenue for 2025 is anticipated to be USD 11.59 billion.
Published Date: Mar-2025
